Belysse Group NV (EBR:BELYS)
Belgium
· Delayed Price · Currency is EUR 0.725
0.00 (0.00%)
Mar 9, 2026, 5:35 PM CET
Belysse Group NV Revenue
Belysse Group NV had revenue of 134.63M EUR in the half year ending June 30, 2025, a decrease of -13.48%. This brings the company's revenue in the last twelve months to 270.29M, down -6.81% year-over-year. In the year 2024, Belysse Group NV had annual revenue of 280.38M, down -6.82%.
Revenue (ttm)
270.29M
Revenue Growth
-6.81%
P/S Ratio
0.10
Revenue / Employee
275.81K
Employees
980
Market Cap
26.06M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 280.38M | -20.54M | -6.82% |
| Dec 31, 2023 | 300.92M | -36.51M | -10.82% |
| Dec 31, 2022 | 337.43M | 60.62M | 21.90% |
| Dec 31, 2021 | 276.81M | 18.46M | 7.14% |
| Dec 31, 2020 | 258.36M | -412.80M | -61.51% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| European Medical Solutions | 49.47M |
| Banimmo | 7.72M |
| Accentis | 5.78M |
| Newtree | 4.76M |
| Keyware Technologies NV | 21.63M |
| Sequana Medical NV | 105.50K |
| Celyad Oncology | 186.00K |
| Immo Moury SCA | 3.20M |